China channel feed – Endpoints News

China channel feed

Insilico Medicine, an early force in AI-driven drug R&D, lets IPO plans peter out for second year in a row

9 months ago

Gilead's Kite uncouples from Fosun in China as Yescarta faces coverage obstacles

9 months ago

Congress spars over whether the Biosecure Act is an overdue crackdown or a rushed witch hunt

10 months ago

House passes Biosecure Act, sending Chinese biotech ban to Senate

10 months ago

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

10 months ago

Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer

10 months ago

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

10 months ago

Little-known startup, backed by Foresite and Samsara, swings $60M China I&I deal

10 months ago

Biosecure vote slated for September

10 months ago

Sanofi pauses supply of two flu vaccines in China over ‘unexpected circumstances’

10 months ago

Duality Biologics, an ADC partner of BeiGene and BioNTech, files for Hong Kong IPO

10 months ago

Mubadala, CBC Group ink $680M deal for UCB’s neurology and allergy portfolio in China

10 months ago

Updated: Chinese government indicts Japanese Astellas employee for espionage

10 months ago

WuXi Bio spotlights new US contracts, but profits are down as Biosecure brews

10 months ago

Indian CDMOs unlikely to see sudden surge in clients if China bill passes, execs say

10 months ago

WuXi Biologics’ ADC spinout reports revenue jump despite Biosecure risk

10 months ago

House lawmakers call on FDA to investigate clinical trials run alongside China's military

10 months ago

BioNTech, MediLink to resume trial enrollment for HER3 antibody-drug conjugate after FDA pause

10 months ago

TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO

10 months ago

Pressure from anti-China legislation begins to ripple through biopharma

11 months ago

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

11 months ago

WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US

11 months ago

Weak China demand weighs on Illumina's sales

11 months ago

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China

11 months ago

First page Previous page 2 3 456 7 8 Next page Last page